ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,444Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 807

$724K Total Retail Price of All Prescriptions

Rank: 29 out of 807

699 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 11,538 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 865 708 1 1
LISINOPRIL 715 568 2 2
OMEPRAZOLE 475 401 3 4
LEVOTHYROXINE SODIUM 400 379 4 3
METOPROLOL TARTRATE 384 344 5 8
AMLODIPINE BESYLATE 369 341 6 5
CITALOPRAM HBR 310 274 7 17
ALENDRONATE SODIUM 301 272 8 20
METFORMIN HCL 287 226 9 12
FUROSEMIDE 285 267 10 6
ATENOLOL 284 245 11 7
WARFARIN SODIUM 252 240 12 10
ATORVASTATIN CALCIUM 249 234 13 11
HYDROCHLOROTHIAZIDE 234 230 14 9
METOPROLOL SUCCINATE 226 214 15 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 214 184 16 28
PRAVASTATIN SODIUM 196 179 17 21
LOSARTAN POTASSIUM 178 178 18 14
SERTRALINE HCL 174 165 19 22
ZOLPIDEM TARTRATE 152 105 20 23
TAMSULOSIN HCL 149 149 21 27
FLUTICASONE PROPIONATE 148 107 22 30
ADVAIR DISKUS 147 137 23 33
NAMENDA 144 131 24 54
POTASSIUM CHLORIDE 134 130 25 18
DONEPEZIL HCL 134 134 25 31
RANITIDINE HCL 133 88 27 34
PREDNISONE 122 107 28 24
GEMFIBROZIL 108 55 29 74
LANTUS 105 81 30 45
CRESTOR 102 102 31 32
POLYETHYLENE GLYCOL 3350 100 79 32 40
GLIPIZIDE ER 99 94 33 67
ALLOPURINOL 95 90 34 26
NOVOLOG 93 62 35 84
LOSARTAN-HYDROCHLOROTHIAZIDE 90 90 36 55
CARVEDILOL 90 86 36 35
GABAPENTIN 88 85 38 16
HYDROCODONE-ACETAMINOPHEN 85 82 S3 39 15
CLOPIDOGREL 82 82 40 47
JANUVIA 75 70 41 79
DIGOXIN 73 70 42 41
NEXIUM 72 40 43 68
TRIAMTERENE-HCTZ 69 65 44 29
VENLAFAXINE HCL ER 69 44 44 91
PROAIR HFA 67 43 46 43
NOVOLOG FLEXPEN 67 47 46 75
LANTUS SOLOSTAR 67 52 46 42
DIOVAN HCT 66 66 49 166
TRAMADOL HCL 66 65 49 19
PANTOPRAZOLE SODIUM 65 31 51 44
AVODART 64 64 52 187
CARBIDOPA-LEVODOPA 63 63 53 64
BACLOFEN 61 12 54 123
DIOVAN 58 58 55 46
MIRTAZAPINE 54 43 56 38
AMITRIPTYLINE HCL 54 54 R 56 71
FAMOTIDINE 53 44 58 90
DOXAZOSIN MESYLATE 53 49 58 70
LIPITOR 51 39 60 100
IBUPROFEN 50 0 61 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.